Search

You searched for "Ophthalmoscopy"

2999 results found

A three-way partnership between Nigeria, Tanzania and Northern Ireland

1 June 2015 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
VISION 2020 LINKS between Western Health and Social Care Trust (WHSCT), Altnagelvin Area Hospital, Northern Ireland with first ECWA Eye Hospital, Kano, Nigeria and now also with Mbeya Referral Hospital (MRH), Tanzania, have been beneficial to all three partners. From...

Retinopathy of prematurity

1 April 2014 | | EYE - Vitreo-Retinal
This review article describes the pathophysiology of retinopathy of prematurity (ROP). The authors start by introducing the condition and its incidence. There is extensive information on the pathophysiology mechanisms involved in the condition to include normal and pathological retinal development....

Exudative age-related macular degeneration

1 April 2014 | | EYE - Vitreo-Retinal
The authors looked at macular lesions in eyes with newly diagnosed exudative age-related macular degeneration. The eyes of 23 patients were included and tested for visual acuity, contrast sensitivity, microperimetry, optical coherence tomography (OCT) and fluorescein and indocyanine green angiography....

8th Heidelberg Engineering Academy Research Masterclass

23 May 2023
@17:30 - 20:10

Eye-Opening-Education: What you were not taught in training

8 December 2025
Eye-Opening-Education OPHTHALMOLOGY: What you were not taught in training

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Eye scans detect signs of Parkinson’s disease up to seven years before diagnosis

22 August 2023 | moorfields, Parkinson's disease, Siegfried Wagner, Pearse Keane, UCL Institute of Ophthalmology, early detection
A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation.

UKISCRS 47th Annual Congress Preview

1 November 2023 | | UKISCRS, Eye News, Preview, Congress, Event, Coverage, David Lockington, Paul Ursell, London
Check out the Eye News preview for UKISCRS' 47th Annual Congress in London, 1-3 November.

OSA Insights to Market win praise from members

31 October 2023 | OSA, Meetings, Events, Market insight, Opticians, E-Health
OSA members praised the breadth of optical market insights provided by the Autumn meeting this week as a broad spectrum of suppliers gathered in London, reinforcing the strength of the trade body.

The Worshipful Company Of Spectacle Makers closes 2023 with 9 new liverymen and 1 new court assistant

12 January 2024 | awards, organisation, healthcare professional, allied professions, livery, collaboration
The Worshipful Company of Spectacle Makers brought a successful 2023 to a close with the admission of 9 new Liverymen at its December Court Lunch.

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

15 October 2025 | genetics, neuro-ophthalmology, drugs, new treatments, mitochondrial
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...